These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 33540663)

  • 21. HIF: a master regulator of nutrient availability and metabolic cross-talk in the tumor microenvironment.
    Missiaen R; Lesner NP; Simon MC
    EMBO J; 2023 Mar; 42(6):e112067. PubMed ID: 36808622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic plasticity of cancer cells.
    Raudenská M; Peltanová B; Hönigová K; Navrátil J; Masařík M
    Klin Onkol; 2022; 35(3):195-207. PubMed ID: 35760572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diverse Roads Taken by
    Gkiouli M; Biechl P; Eisenreich W; Otto AM
    Cells; 2019 Sep; 8(10):. PubMed ID: 31547005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adapt and conquer: Metabolic flexibility in cancer growth, invasion and evasion.
    Kreuzaler P; Panina Y; Segal J; Yuneva M
    Mol Metab; 2020 Mar; 33():83-101. PubMed ID: 31668988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism shapes the tumor microenvironment.
    Reina-Campos M; Moscat J; Diaz-Meco M
    Curr Opin Cell Biol; 2017 Oct; 48():47-53. PubMed ID: 28605656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of Glutamine Dependency and Metabolic Rescue Protocols.
    Qie S; He D; Sang N
    Methods Mol Biol; 2019; 1928():427-439. PubMed ID: 30725468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolites in the Tumor Microenvironment Reprogram Functions of Immune Effector Cells Through Epigenetic Modifications.
    Li Y; Wu Y; Hu Y
    Front Immunol; 2021; 12():641883. PubMed ID: 33927716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer metabolism at a glance.
    Vazquez A; Kamphorst JJ; Markert EK; Schug ZT; Tardito S; Gottlieb E
    J Cell Sci; 2016 Sep; 129(18):3367-73. PubMed ID: 27635066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic Constants and Plasticity of Cancer Cells in a Limiting Glucose and Glutamine Microenvironment-A Pyruvate Perspective.
    Otto AM
    Front Oncol; 2020; 10():596197. PubMed ID: 33425750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nutrient metabolism and cancer in the in vivo context: a metabolic game of give and take.
    Altea-Manzano P; Cuadros AM; Broadfield LA; Fendt SM
    EMBO Rep; 2020 Oct; 21(10):e50635. PubMed ID: 32964587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment.
    Ackerman D; Simon MC
    Trends Cell Biol; 2014 Aug; 24(8):472-8. PubMed ID: 24985940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct metabolic responses of an ovarian cancer stem cell line.
    Vermeersch KA; Wang L; McDonald JF; Styczynski MP
    BMC Syst Biol; 2014 Dec; 8():134. PubMed ID: 25518943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic Remodeling as a Way of Adapting to Tumor Microenvironment (TME), a Job of Several Holders.
    Serpa J
    Adv Exp Med Biol; 2020; 1219():1-34. PubMed ID: 32130691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment.
    Nachef M; Ali AK; Almutairi SM; Lee SH
    Front Immunol; 2021; 12():624324. PubMed ID: 33953707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of YAP/TAZ activity in cancer metabolic reprogramming.
    Zhang X; Zhao H; Li Y; Xia D; Yang L; Ma Y; Li H
    Mol Cancer; 2018 Sep; 17(1):134. PubMed ID: 30176928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Translating In Vitro T Cell Metabolic Findings to In Vivo Tumor Models of Nutrient Competition.
    Ecker C; Riley JL
    Cell Metab; 2018 Aug; 28(2):190-195. PubMed ID: 30089240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic Plasticity of Tumor Cells: How They Do Adapt to Food Deprivation.
    Schoonjans CA; Gallez B
    Adv Exp Med Biol; 2020; 1219():109-123. PubMed ID: 32130696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iron and cancer: more ore to be mined.
    Torti SV; Torti FM
    Nat Rev Cancer; 2013 May; 13(5):342-55. PubMed ID: 23594855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxygen availability and metabolic adaptations.
    Nakazawa MS; Keith B; Simon MC
    Nat Rev Cancer; 2016 Sep; 16(10):663-73. PubMed ID: 27658636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic heterogeneity in cancer: An overview and therapeutic implications.
    Tong Y; Gao WQ; Liu Y
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188421. PubMed ID: 32835766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.